Related Experiment Video
Updated: Jun 18, 2026

Murine Bilateral Renal Lymphadenectomy
Published on: December 30, 2025
Bilateral renal inflammatory pseudotumour effectively treated with corticosteroid
Jordan Yuanzhi Li1, Tuck Y Yong, Mark Coleman
1Department of Nephrology, Flinders Medical Centre, Flinders University, Bedford Park, Adelaide, SA 5042, Australia. jordan.li@health.sa.gov.au
Inflammatory pseudotumour (IPT) is a rare kidney condition. This case highlights bilateral renal IPT, emphasizing diagnostic challenges and common treatments like nephrectomy and corticosteroids.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Inflammatory pseudotumour (IPT) is a rare neoplastic-like lesion of unknown etiology.
- While commonly affecting the lungs, IPT can occur in virtually any organ system.
- Renal involvement is exceptionally rare, with bilateral cases being even rarer.
Observation:
- This report details an extremely rare case of bilateral renal inflammatory pseudotumour.
- Clinical presentations are often nonspecific, complicating early diagnosis.
- Radiological imaging is insufficient for definitive diagnosis, often necessitating surgical intervention or biopsy.
Findings:
- A comprehensive review of 34 previously reported renal IPT cases (1966-2008) was conducted.
- The majority of renal IPT cases (83%) were treated with nephrectomy.
- Bilateral renal IPT cases were predominantly managed with corticosteroids.
Implications:
- The rarity and nonspecific presentation of renal IPT pose significant diagnostic challenges.
- Distinguishing renal IPT from malignancy based on imaging alone is difficult.
- Nephrectomy and corticosteroids represent primary treatment modalities for renal IPT, particularly in bilateral cases.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Acute Pyelonephritis II: Diagnostic Studies and Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

